je.st
news
Bayer HealthCare Statement
2014-02-12 22:40:54| Chemicals - Topix.net
The joint Advisory Committee panel reviewed the data and analyses published since the last non-steroidal anti-inflammatory drug panel review in 2005 to further understand the relationship between cardiovascular thrombotic risk and prescription and over-the-counter non-aspirin NSAIDs already described in the class labeling.
Tags: statement
healthcare
bayer
bayer healthcare
Category:Chemicals